Archive | Between Sessions Brief

All Briefs

GLP-1s and Addiction, Tennessee's AI Law, and Alma's AI Layoffs

Apr 14, 2026

A large WashU study links GLP-1 medications to lower rates of substance use disorders, and Tennessee just became the first state to give clients legal standing against AI tools marketed as therapy. We also cover Alma's AI-driven layoffs, single-session therapy's growing reach, and a psychiatrist's pointed critique of the second victim framework.

New HIPAA Rules, Parity Changes, AI Scribe Findings

Apr 7, 2026

This week brought a parity rule reversal, a postpartum depression drug trial miss, and the most rigorous look yet at what AI scribes actually do to clinical workload. We also cover HIPAA Security Rule finalization and what patients with dismissed symptoms are doing with AI before they arrive in your office.

Medicaid Cuts, ICE Guidance, and Words That Matter

Mar 31, 2026

Federal Medicaid cuts are putting more pressure on already-strained psychiatric units, and a new investigation found that $25 million in Georgia parity fines haven't been collected. We also cover ICE guidance for clinical settings, a DBT vs. SSRI trial, and an encouraging look into AI scribes in mental health.